Warning issued over Pradaxa

Published: 2012-12-26 06:59:00

Updated: 2012-12-26 06:59:00

The Korea Food and Drug Administration said last Friday that individuals with prosthetic heart valves should not use Pradaxa, after data from a recently stopped clinical trial revealed that the newer blood thinner may increase the risk of strokes, heart attacks, blood clots and other serious prob...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK